Arovella Therapeutics LimitedASX: ALA

Approval for South African multi dose phase 1 clinical trial

Feb 10, 2016 at 8:19 PM EST · Issued by Arovella Therapeutics Limited

Filed with ASX · Feb 10, 2016 at 8:19 PM EST

6ix hasn’t read this filing yet.

Follow Arovella Therapeutics into a list and get an email when it puts out news.